SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Trader J's Inner Circle
NVDA 182.35-0.6%Dec 5 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (25019)12/30/1999 2:42:00 PM
From: Mike McFarland  Read Replies (2) of 56535
 
Biotech position trades--well I'm at
my wits end with that Axys, it barks
like a dog and yet when I went back
and read the latest quarterly report
and the fancy annual they sent me, I
cant find any good reason to trade out
of it, even if it turned out to be
a suck daytrade.

fwiw there has been good volume on my
other larger positions too--and ARIA has
even been trending up nicely. GZMO has
been doing okay for me, but the volume isn't
spectaular. On my gene therapy list ONXX and
TGEN are doing well, I own the latter and
wish I still owned some of the former. I
actually, gasp, gave up the rest of my
Valentis, VLTS, for the time being. I don't
know what happened to being a good investor
and keeping the half that was "paid for".

Guess I temporarily came down with the trading
bug, it stopped going up, what can I say?

I know there are gobs of non-biotech daytrades
out there, but fun to post I guess. Contemplating
giving up that AXPH--if anybody reads these biotech
posts of mine, I'd appreciate any thoughts on what
the increased volume in that one means--bullish
for high volume but steady price? I hope so.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext